The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA

In 2012, the United States Preventive Services Task Force (USPSTF) issued a Grade D (against screening) recommendation for PSA screening for prostate cancerRates of PSA screening, prostate biopsy and overall prostate cancer incidence declined in the first few years after the recommendation, with a shift towards higher grade and stage of prostate tumours at the time of detectionDespite the recommendation, some physicians report ongoing willingness to screen appropriately selected men, and many men report that they intend to continue to ask for the PSA test from their doctorIncreased follow-up durations are needed in order to understand whether the decreased rates of PSA screening will effect prostate cancer metastasis and mortality